Guangshuai Zhang, Yingyan Liao, Ziyu Tan, Qingqing Xie, Zishu Liu, Jin Xiao et al. Structure-based virtual high-throughput screening and molecular dynamics simulations for repurposing FDA-approved drugs as STAT3 inhibitors. // Current Pharmaceutical Analysis. – 2026. – DOI: 10.1016/j.cpan.2026.11.003. – URL: https://doi.org/10.1016/j.cpan.2026.11.003
Guangshuai Zhang, Yingyan Liao, Ziyu Tan, Qingqing Xie, Zishu Liu, Jin Xiao, Si Yan, Xiaoqian Guo, Rui Peng, Wei Luo, & Shuanglin Qin (2026). Structure-based virtual high-throughput screening and molecular dynamics simulations for repurposing FDA-approved drugs as STAT3 inhibitors. Current Pharmaceutical Analysis. https://doi.org/10.1016/j.cpan.2026.11.003
Guangshuai Zhang, et al. “Structure-based virtual high-throughput screening and molecular dynamics simulations for repurposing FDA-approved drugs as STAT3 inhibitors.” Current Pharmaceutical Analysis, 2026. doi:10.1016/j.cpan.2026.11.003.
@article{Zhang2026,
title = {Structure-based virtual high-throughput screening and molecular dynamics simulations for repurposing FDA-approved drugs as STAT3 inhibitors},
author = {Zhang, Guangshuai and Liao, Yingyan and Tan, Ziyu and Xie, Qingqing and Liu, Zishu and Xiao, Jin and Yan, Si and Guo, Xiaoqian and Peng, Rui and Luo, Wei and Qin, Shuanglin},
journal = {Current Pharmaceutical Analysis},
year = {2026},
doi = {10.1016/j.cpan.2026.11.003},
url = {https://doi.org/10.1016/j.cpan.2026.11.003}
}